Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Latest Events
Latest News
Product & Service
BIO International Convention, Boston, MA
June. 5-8, 2023
CPhI China, Shanghai
Booth # W2B20b
June. 19-21, 2023
Formosalab receives TFDA approval for Eribulin Mesylate injectable 2023-02-22
TW Patent No. I784646 entitled METHOD FOR PREPARING FERRIC CARBOXYMALTOSE was granted on Nov 21, 2022. 2022-12-08
Formosa Labs’ fermentation production line was successfully inspected by US FDA in November 2022. 2022-11-15
TW Patent No. I781345 entitled Crystalline form of Baricitinib and method for preparation thereof was granted on Oct 21, 2022. 2022-11-08
Formosa has won the Talent Quality-management System (TTQS) Bronze Medal Award. 2022-11-07
Active Pharmaceutical Ingredients
Contract Development and Manufacturing Organization (CDMO)
Antibody Drug Conjugates (ADCs)
Injectable Manufacturing Services

Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.